ADMA Biologics Inc (ADMA)

Total asset turnover

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Revenue (ttm)	US$ in thousands	382,809	330,245	283,177	258,216	234,293	208,108	181,890	154,079	130,481	110,072	93,998	80,944	68,517	58,112	48,069	42,220	40,301	37,248	36,021	29,350
Total assets	US$ in thousands	390,618	376,399	350,875	329,182	348,997	343,027	340,788	348,461	300,558	296,932	308,032	276,253	238,640	232,814	235,667	207,673	189,976	191,542	210,524	127,091
Total asset turnover		0.98	0.88	0.81	0.78	0.67	0.61	0.53	0.44	0.43	0.37	0.31	0.29	0.29	0.25	0.20	0.20	0.21	0.19	0.17	0.23

September 30, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $382,809K ÷ $390,618K
= 0.98

The total asset turnover ratio of ADMA Biologics Inc has shown a generally increasing trend over the past few years, indicating improvement in the company's efficiency in generating sales from its assets. As of September 30, 2024, the total asset turnover ratio stands at 0.98, signifying that the company generates $0.98 in sales for every dollar of assets it holds. This ratio has consistently improved from 0.17 in December 2019 to the current level, reflecting enhanced utilization of assets to drive revenue growth. The upward trend suggests that ADMA Biologics Inc has been more effective in managing its assets and converting them into revenue, which could potentially contribute to enhancing the company's profitability and overall financial performance.